Vitamin D Receptor

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 23226 Experts worldwide ranked by ideXlab platform

James K. Friel - One of the best experts on this subject based on the ideXlab platform.

Philip Martin - One of the best experts on this subject based on the ideXlab platform.

  • Vitamin D Receptor meDiateD stromal reprogramming suppresses pancreatitis anD enhances pancreatic cancer therapy
    Cell, 2014
    Co-Authors: Mara H Sherman, Ning Ding, Annette R Atkins, Dannielle D Engle, Herve Tiriac, Eric A Collisson, Frances Connor, Terry Van Dyke, Serguei Kozlov, Philip Martin
    Abstract:

    The poor clinical outcome in pancreatic Ductal aDenocarcinoma (PDA) is attributeD to intrinsic chemoresistance anD a growth-permissive tumor microenvironment. Conversion of quiescent to activateD pancreatic stellate cells (PSCs) Drives the severe stromal reaction that characterizes PDA. Here, we reveal that the Vitamin D Receptor (VDR) is expresseD in stroma from human pancreatic tumors anD that treatment with the VDR liganD calcipotriol markeDly reDuceD markers of inflammation anD fibrosis in pancreatitis anD human tumor stroma. We show that VDR acts as a master transcriptional regulator of PSCs to reprise the quiescent state, resulting in inDuceD stromal remoDeling, increaseD intratumoral gemcitabine, reDuceD tumor volume, anD a 57% increase in survival compareD to chemotherapy alone. This work Describes a molecular strategy through which transcriptional reprogramming of tumor stroma enables chemotherapeutic response anD suggests Vitamin D priming as an aDjunct in PDA therapy. PAPERFLICK:

Mara H Sherman - One of the best experts on this subject based on the ideXlab platform.

  • Vitamin D Receptor meDiateD stromal reprogramming suppresses pancreatitis anD enhances pancreatic cancer therapy
    Cell, 2014
    Co-Authors: Mara H Sherman, Ning Ding, Annette R Atkins, Dannielle D Engle, Herve Tiriac, Eric A Collisson, Frances Connor, Terry Van Dyke, Serguei Kozlov, Philip Martin
    Abstract:

    The poor clinical outcome in pancreatic Ductal aDenocarcinoma (PDA) is attributeD to intrinsic chemoresistance anD a growth-permissive tumor microenvironment. Conversion of quiescent to activateD pancreatic stellate cells (PSCs) Drives the severe stromal reaction that characterizes PDA. Here, we reveal that the Vitamin D Receptor (VDR) is expresseD in stroma from human pancreatic tumors anD that treatment with the VDR liganD calcipotriol markeDly reDuceD markers of inflammation anD fibrosis in pancreatitis anD human tumor stroma. We show that VDR acts as a master transcriptional regulator of PSCs to reprise the quiescent state, resulting in inDuceD stromal remoDeling, increaseD intratumoral gemcitabine, reDuceD tumor volume, anD a 57% increase in survival compareD to chemotherapy alone. This work Describes a molecular strategy through which transcriptional reprogramming of tumor stroma enables chemotherapeutic response anD suggests Vitamin D priming as an aDjunct in PDA therapy. PAPERFLICK:

  • a Vitamin D Receptor smaD genomic circuit gates hepatic fibrotic response
    Cell, 2013
    Co-Authors: Ning Ding, Nanthakumar Subramaniam, Mara H Sherman, Caroline L Wilson, Renuka Rao, Mathias Leblanc, Sally Coulter, Christopher Scott, Sue L Lau, Annette R Atkins
    Abstract:

    Liver fibrosis is a reversible wounD-healing response involving TGFβ1/SMAD activation of hepatic stellate cells (HSCs). It results from excessive Deposition of extracellular matrix components anD can leaD to impairment of liver function. Here, we show that Vitamin D Receptor (VDR) liganDs inhibit HSC activation by TGFβ1 anD abrogate liver fibrosis, whereas VDr knockout mice spontaneously Develop hepatic fibrosis. Mechanistically, we show that TGFβ1 signaling causes a reDistribution of genome-wiDe VDR-binDing sites (VDR cistrome) in HSCs anD facilitates VDR binDing at SMAD3 profibrotic target genes via TGFβ1-DepenDent chromatin remoDeling. In the presence of VDR liganDs, VDR binDing to the coregulateD genes reDuces SMAD3 occupancy at these sites, inhibiting fibrosis. These results reveal an intersecting VDR/SMAD genomic circuit that regulates hepatic fibrogenesis anD Define a role for VDR as an enDocrine checkpoint to moDulate the wounD-healing response in liver. Furthermore, the finDings suggest VDR liganDs as a potential therapy for liver fibrosis.

Kimberly O Obrien - One of the best experts on this subject based on the ideXlab platform.

Ning Ding - One of the best experts on this subject based on the ideXlab platform.

  • Vitamin D Receptor meDiateD stromal reprogramming suppresses pancreatitis anD enhances pancreatic cancer therapy
    Cell, 2014
    Co-Authors: Mara H Sherman, Ning Ding, Annette R Atkins, Dannielle D Engle, Herve Tiriac, Eric A Collisson, Frances Connor, Terry Van Dyke, Serguei Kozlov, Philip Martin
    Abstract:

    The poor clinical outcome in pancreatic Ductal aDenocarcinoma (PDA) is attributeD to intrinsic chemoresistance anD a growth-permissive tumor microenvironment. Conversion of quiescent to activateD pancreatic stellate cells (PSCs) Drives the severe stromal reaction that characterizes PDA. Here, we reveal that the Vitamin D Receptor (VDR) is expresseD in stroma from human pancreatic tumors anD that treatment with the VDR liganD calcipotriol markeDly reDuceD markers of inflammation anD fibrosis in pancreatitis anD human tumor stroma. We show that VDR acts as a master transcriptional regulator of PSCs to reprise the quiescent state, resulting in inDuceD stromal remoDeling, increaseD intratumoral gemcitabine, reDuceD tumor volume, anD a 57% increase in survival compareD to chemotherapy alone. This work Describes a molecular strategy through which transcriptional reprogramming of tumor stroma enables chemotherapeutic response anD suggests Vitamin D priming as an aDjunct in PDA therapy. PAPERFLICK:

  • a Vitamin D Receptor smaD genomic circuit gates hepatic fibrotic response
    Cell, 2013
    Co-Authors: Ning Ding, Nanthakumar Subramaniam, Mara H Sherman, Caroline L Wilson, Renuka Rao, Mathias Leblanc, Sally Coulter, Christopher Scott, Sue L Lau, Annette R Atkins
    Abstract:

    Liver fibrosis is a reversible wounD-healing response involving TGFβ1/SMAD activation of hepatic stellate cells (HSCs). It results from excessive Deposition of extracellular matrix components anD can leaD to impairment of liver function. Here, we show that Vitamin D Receptor (VDR) liganDs inhibit HSC activation by TGFβ1 anD abrogate liver fibrosis, whereas VDr knockout mice spontaneously Develop hepatic fibrosis. Mechanistically, we show that TGFβ1 signaling causes a reDistribution of genome-wiDe VDR-binDing sites (VDR cistrome) in HSCs anD facilitates VDR binDing at SMAD3 profibrotic target genes via TGFβ1-DepenDent chromatin remoDeling. In the presence of VDR liganDs, VDR binDing to the coregulateD genes reDuces SMAD3 occupancy at these sites, inhibiting fibrosis. These results reveal an intersecting VDR/SMAD genomic circuit that regulates hepatic fibrogenesis anD Define a role for VDR as an enDocrine checkpoint to moDulate the wounD-healing response in liver. Furthermore, the finDings suggest VDR liganDs as a potential therapy for liver fibrosis.